Mount Sinai returned to roughly break-even in 2025 after a steep 2024 loss, helped by pharmacy revenue and cost moves including the Beth Israel closure.

Memorial Hermann’s Life Flight campaign reached $60M at its spring gala, securing five new helicopters and launching a TIRR campus initiative to strengthen Houston trauma care.

State regulators recalled a Sinse prepackaged cannabis flower after state tests found Aspergillus. Officials say no illnesses have been reported and returns are being accepted.

A UTEP study found Valley fever cases in El Paso more than tripled from 2013–2022 and linked spikes to extreme heat, strong winds and dust storms. The researchers say environmental signals could help officials anticipate risk.

U.S. life expectancy hit 79, but longer lives mean more years of costly care — and many households aren't ready.

Three people died and several others fell ill after a suspected hantavirus outbreak on a cruise ship near Cape Verde. WHO and national authorities are coordinating evacuations while tests continue.

SBH filed plans for about $132M to expand its Bronx emergency department and add inpatient psychiatric capacity in a multi‑year overhaul. State paperwork outlines a 2026 construction start for the psychiatry work.

Andrew "Andy" Guz, currently CEO of Manatee Health, will take over as president and CEO of Columbus Regional Health on July 1, 2026.

Carlos Migoya will step down May 31 and Jackson’s board has named President/COO David Zambrana as his successor. The change arrives as the system navigates budget cuts, a maternity‑ward closure and a foundation fraud scandal.

A Cedars‑Sinai‑led pilot found an antibody‑coated blood filter lowered sFlt‑1 and delayed delivery by about 10 days in 16 women with very preterm preeclampsia; larger trials are needed.

West Coast health officials recommend a second 2025–26 COVID‑19 vaccine dose for adults 65+ roughly six months after the first. Officials say the updated shots target JN.1 and are covered by Medicare Part B.

A randomized trial reported higher rates of complete tumor disappearance when women took 2,000 IU vitamin D daily during neoadjuvant chemotherapy. Experts say larger trials are needed before changing practice.

A backend Medicare dataset left providers’ Social Security numbers exposed for weeks, prompting officials to pull the files and pledge fixes. Coverage shows providers and lawmakers want answers.